001017565 001__ 1017565
001017565 005__ 20240223132827.0
001017565 0247_ $$2doi$$a10.3389/fmolb.2023.1120416
001017565 0247_ $$2datacite_doi$$a10.34734/FZJ-2023-04205
001017565 0247_ $$2pmid$$a36845541
001017565 0247_ $$2WOS$$aWOS:000937088500001
001017565 037__ $$aFZJ-2023-04205
001017565 082__ $$a570
001017565 1001_ $$0P:(DE-HGF)0$$aMuschol, Martin$$b0
001017565 245__ $$aAmyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils
001017565 260__ $$aLausanne$$bFrontiers$$c2023
001017565 3367_ $$2DataCite$$aOutput Types/Book Review
001017565 3367_ $$0PUB:(DE-HGF)36$$2PUB:(DE-HGF)$$aReview$$breview$$mreview$$s1698994144_5474
001017565 3367_ $$2ORCID$$aBOOK_REVIEW
001017565 3367_ $$2DRIVER$$areview
001017565 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$mjournal
001017565 3367_ $$2BibTeX$$aARTICLE
001017565 3367_ $$00$$2EndNote$$aJournal Article
001017565 520__ $$aAmyloid Diseases involve the growth of disease specific proteins into amyloid fibrils and their deposition in protein plaques. Amyloid fibril formation is typically preceded by oligomeric intermediates. Despite significant efforts, the specific role fibrils or oligomers play in the etiology of any given amyloid disease remains controversial. In neurodegenerative disease, though, amyloid oligomers are widely considered critical contributors to disease symptoms. Aside from oligomers as inevitable on-pathway precursors of fibril formation, there is significant evidence for off-pathway oligomer formation competing with fibril growth. The distinct mechanisms and pathways of oligomer formation directly affect our understanding under which conditions oligomers emerge in vivo, and whether their formation is directly coupled to, or distinct from, amyloid fibril formation. In this review, we will discuss the basic energy landscapes underlying the formation of on-pathway vs. off-pathway oligomers, their relation to the related amyloid aggregation kinetics, and their resulting implications for disease etiology. We will review evidence on how differences in the local environment of amyloid assembly can dramatically shift the relative preponderance of oligomers vs. fibrils. Finally, we will comment on gaps in our knowledge of oligomer assembly, of their structure, and on how to assess their relevance to disease etiology.
001017565 536__ $$0G:(DE-HGF)POF4-5244$$a5244 - Information Processing in Neuronal Networks (POF4-524)$$cPOF4-524$$fPOF IV$$x0
001017565 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001017565 7001_ $$0P:(DE-Juel1)201143$$aHoyer, Wolfgang$$b1$$eCorresponding author
001017565 773__ $$0PERI:(DE-600)2814330-9$$a10.3389/fmolb.2023.1120416$$gVol. 10, p. 1120416$$p1120416$$tFrontiers in molecular biosciences$$v10$$x2296-889X$$y2023
001017565 8564_ $$uhttps://juser.fz-juelich.de/record/1017565/files/fmolb-10-1120416.pdf$$yOpenAccess
001017565 909CO $$ooai:juser.fz-juelich.de:1017565$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
001017565 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)201143$$aForschungszentrum Jülich$$b1$$kFZJ
001017565 9131_ $$0G:(DE-HGF)POF4-524$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5244$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vMolecular and Cellular Information Processing$$x0
001017565 9141_ $$y2023
001017565 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-26
001017565 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-26
001017565 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001017565 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-11T12:25:52Z
001017565 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-11T12:25:52Z
001017565 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-26
001017565 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-26
001017565 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001017565 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2021-05-11T12:25:52Z
001017565 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-26
001017565 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT MOL BIOSCI : 2022$$d2024-02-05
001017565 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-02-05
001017565 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-02-05
001017565 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2024-02-05
001017565 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-02-05
001017565 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-02-05
001017565 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-02-05
001017565 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bFRONT MOL BIOSCI : 2022$$d2024-02-05
001017565 920__ $$lyes
001017565 9201_ $$0I:(DE-Juel1)IBI-7-20200312$$kIBI-7$$lStrukturbiochemie$$x0
001017565 980__ $$areview
001017565 980__ $$aVDB
001017565 980__ $$aUNRESTRICTED
001017565 980__ $$ajournal
001017565 980__ $$aI:(DE-Juel1)IBI-7-20200312
001017565 9801_ $$aFullTexts